CommentaryTranslational Research

From Free to Free Market: Cost Recovery in Federally Funded Clinical Research

See allHide authors and affiliations

Science Translational Medicine  04 Jul 2012:
Vol. 4, Issue 141, pp. 141cm7
DOI: 10.1126/scitranslmed.3003589
  • Fig. 1. The path to CRM implementation.

    Features common to successful models within the CTSA consortium can be broadly categorized into five integral components involving decision-making steps that are based on due diligence and expert counsel. Making that model robust requires additional components that form an effective A21 compliance system. From experience, CTSA institutions have also developed a range of supporting systems to ameliorate their individual model.

    CREDIT: B. STRAUCH/SCIENCE TRANSLATIONAL MEDICINE
  • Fig. 2. A CRM implementation plan.

    On the basis of feedback from CSCs, we designed a “how-to” timeline that details CRM implementation over an 8-month period. Although some components can be initiated concomitantly, others build on the results of previous steps. The primary timeline includes components from Fig. 1, with an additional step to present the draft CRM to stakeholders to obtain valuable feedback and/or identify bottlenecks before the model is finalized.

    CREDIT: B. STRAUCH/SCIENCE TRANSLATIONAL MEDICINE

Additional Files

  • Supplementary Materials for:

    From Free to Free Market: Cost Recovery in Federally Funded Clinical Research

    Margaret G. McCammon, Thomas T. Fogg, Lynda Jacobsen, John Roache, Royce Sampson, Cynthia L. Bower*

    *To whom correspondence should be addressed. E-mail: bower{at}med.umich.edu

    Published 4 July 2012, Sci.Transl. Med. 4, 141cm7 (2012)
    DOI: 10.1126/scitranslmed.3003589

    This PDF file includes:

    1. Methods
    2. Fig. S1
    3. Tables S1 to S3

    [Download PDF]

Stay Connected to Science Translational Medicine

Navigate This Article